Home Arkis Biosciences

Arkis Biosciences

acquired
Series A
Provider of Advanced Implant Technologies and Minimally Invasive Surgical Instruments

Basic Information

Arkis BioSciences develops, markets, and sells advanced catheters and minimally invasive instruments for neurosurgical procedures. Arkis' proprietary catheters utilize Endexo, designed to reduce catheter-related complications, while the company’s instruments are engineered to be less invasive across various neurosurgical operations. Overall, the company’s product portfolio enables healthcare practitioners to potentially reduce surgical trauma, shorten operation times, and minimize treatment complications.
Arkis BioSciences, Inc.
Tennessee,United States of America
15~50 people
January 01, 2011
info@arkisbiosciences.com